Exact Mass: 595.2101

Exact Mass Matches: 595.2101

Found 23 metabolites which its exact mass value is equals to given mass value 595.2101, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Pyrrolino-dox

10-{[4-(2,3-dihydro-1H-pyrrol-1-yl)-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C31H33NO11 (595.2054)


   
   

Ethyl N-methylpiperidine-3-carboxylate

Ethyl N-methylpiperidine-3-carboxylate

C27H32F3N5O5S (595.2076)


   
   

Glu Met Met Trp

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Glu Met Trp Met

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Glu Trp Met Met

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Met Glu Met Trp

(4S)-4-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Met Glu Trp Met

(4S)-4-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Met Met Glu Trp

(4S)-4-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Met Met Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C26H37N5O7S2 (595.2134)


   

Met Trp Glu Met

(4S)-4-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Met Trp Met Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]pentanedioic acid

C26H37N5O7S2 (595.2134)


   

Trp Glu Met Met

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Trp Met Glu Met

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C26H37N5O7S2 (595.2134)


   

Trp Met Met Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]pentanedioic acid

C26H37N5O7S2 (595.2134)


   

Tauroselcholic acid

Tauroselcholic acid

C26H45NO7SSe (595.2082)


   

Tauroselcholic acid se-75

Tauroselcholic acid se-75

C26H45NO7SSe (595.2082)


V - Various > V09 - Diagnostic radiopharmaceuticals > V09D - Hepatic and reticulo endothelial system D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

1,3-benzodioxol-5-yl-[(3R)-4-[3-(4-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-6-[4-morpholinyl(oxo)methyl]-1,3-dihydropyrrolo[3,4-c]pyridin-2-yl]methanone

1,3-benzodioxol-5-yl-[(3R)-4-[3-(4-fluorophenyl)phenyl]-3-(2-hydroxyethyl)-6-[4-morpholinyl(oxo)methyl]-1,3-dihydropyrrolo[3,4-c]pyridin-2-yl]methanone

C34H30FN3O6 (595.2119)


   

RGX-104

RGX-104

C34H33ClF3NO3 (595.2101)


RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.

   

n-{[(2e,3r,4r,5s)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene][(2-oxopropyl)-c-hydroxycarbonimidoyl]methyl}-2-(3-methoxy-5-methylnaphthalene-1-carbonyloxy)-2-(2-methyloxiran-2-yl)ethanimidic acid

n-{[(2e,3r,4r,5s)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene][(2-oxopropyl)-c-hydroxycarbonimidoyl]methyl}-2-(3-methoxy-5-methylnaphthalene-1-carbonyloxy)-2-(2-methyloxiran-2-yl)ethanimidic acid

C30H33N3O10 (595.2166)


   

2-[methyl(2-[(r)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl]-1,3-benzodiazole-1-carbonyl)amino]ethyl 1-methylpiperidine-4-carboxylate

2-[methyl(2-[(r)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl]-1,3-benzodiazole-1-carbonyl)amino]ethyl 1-methylpiperidine-4-carboxylate

C27H32F3N5O5S (595.2076)


   

2-[(2e,3r,4r,5s)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene]-2-{[(2s)-1-hydroxy-2-(3-methoxy-5-methylnaphthalene-1-carbonyloxy)-2-[(2s)-2-methyloxiran-2-yl]ethylidene]amino}-n-(2-oxopropyl)ethanimidic acid

2-[(2e,3r,4r,5s)-3-(acetyloxy)-4-hydroxy-1-azabicyclo[3.1.0]hexan-2-ylidene]-2-{[(2s)-1-hydroxy-2-(3-methoxy-5-methylnaphthalene-1-carbonyloxy)-2-[(2s)-2-methyloxiran-2-yl]ethylidene]amino}-n-(2-oxopropyl)ethanimidic acid

C30H33N3O10 (595.2166)